Best Pharmacology Journals (2026): Ranked by Impact and Accessibility

Elite Tier (IF 10+)

Nature Reviews Drug Discovery is in a category of its own with an IF of 101.8, by far the highest in pharmacology. It publishes reviews, perspectives, and news about the drug discovery pipeline. Getting a paper in NRDD is essentially by invitation, or through a compelling proposal that the editors commission. For most pharmacologists, this is aspirational reading rather than a realistic publication target.

Pharmacological Reviews is ASPET's review journal and publishes some of the most cited reviews in the field. Each review is a thorough treatment of a pharmacological topic, often 50+ pages. If you're the leading authority on a receptor system, drug class, or therapeutic area, this is where you publish your definitive review. The IF of 17.3 reflects the lasting value of these articles.

Trends in Pharmacological Sciences from Cell Press publishes shorter, more opinion-oriented reviews. It's a great venue for new ideas, emerging concepts, and forward-looking pieces. The editorial team actively commissions content, but unsolicited submissions are considered.

Drug Resistance Updates has an IF of 21.7 and covers drug resistance in cancer, infectious disease, and other therapeutic areas. It's highly specialized, but if your work addresses resistance mechanisms, it's the perfect fit and widely read by both basic and clinical researchers.

Strong Tier (IF 4-7)

British Journal of Pharmacology is the flagship of the British Pharmacological Society and one of the most respected primary research journals in the field. BJP has strong editorial standards, particularly around reproducibility. The journal requires detailed reporting of experimental methods, including group sizes, randomization, and blinding. This emphasis on rigor has maintained its reputation even as other journals have loosened standards.

Clinical Pharmacology & Therapeutics is ASCPT's journal and the standard bearer for clinical pharmacology research. It publishes clinical drug studies, pharmacokinetics, pharmacogenomics, and regulatory science. If your work involves human subjects and drug therapy, this is the most targeted and respected outlet.

Biochemical Pharmacology bridges biochemistry and pharmacology, publishing papers on drug mechanisms at the molecular and cellular level. It's published by Elsevier and has a long history in the field. Enzyme inhibition studies, receptor pharmacology, and drug metabolism work all fit well.

European Journal of Pharmacology covers all areas of pharmacology with a somewhat broader and more accessible scope. It's a reliable choice for solid pharmacological work that doesn't quite reach the BJP or CPT level. The acceptance rate of 30% and the fast review times make it practical.

Accessible Tier (IF 2-4)

Journal of Pharmacology and Experimental Therapeutics is ASPET's primary research journal and one of the oldest pharmacology journals in the world. Its IF of 3.5 doesn't capture its historical weight or its influence within the American pharmacology community. If you're doing classical in vivo pharmacology or in vitro receptor studies, JPET's readership is your community.

Molecular Pharmacology is also from ASPET and focuses on molecular mechanisms of drug action. It's the natural home for receptor structure-function studies, signaling pathway analysis, and drug-target interactions. The IF of 3.2 is modest, but the community reads it.

Naunyn-Schmiedeberg's Archives of Pharmacology is the oldest pharmacology journal, founded in 1873. It maintains a European readership and publishes across all pharmacological disciplines. The journal carries historical prestige that its current IF doesn't fully reflect.

Open Access Accessible Tier

Frontiers in Pharmacology (IF 4.4) is the largest OA journal in pharmacology by volume. It publishes across all subfields and uses Frontiers' collaborative review model. Quality is uneven because of the sheer volume, but well-done papers get good visibility. The APC of $2,950 is reasonable for OA.

Pharmacology Research & Perspectives is jointly published by ASPET and BPS, which gives it society backing. It's fully OA with an APC of $2,400. The journal aims to publish rigorous pharmacological research regardless of perceived novelty, which makes it a good option for replication studies and negative results.

British Journal of Pharmacology stands out for its commitment to experimental rigor. The journal introduced guidelines for experimental design and data reporting that have influenced the entire field. Reviewers check statistical methods carefully, and papers with weak experimental designs get rejected even if the results are interesting. This makes BJP papers particularly trustworthy.

Clinical Pharmacology & Therapeutics is read by clinical pharmacologists, regulatory scientists, and pharmaceutical industry professionals. Papers with direct clinical implications, especially in pharmacokinetics, drug-drug interactions, and pharmacogenomics, do best here. The journal also publishes position papers and white papers on regulatory topics.

Biochemical Pharmacology attracts a chemistry-aware pharmacology readership. If your paper involves detailed enzyme kinetics, binding assays, or metabolic pathway analysis, BP's audience will appreciate the methodology. Papers that are too clinical or too in vivo often get redirected to other journals.

JPET is unpretentious and valued. It publishes straightforward pharmacological studies with clear dose-response data and appropriate controls. The review process is fair, and the editors respect traditional pharmacological methods. It's a good home for well-executed studies that don't claim to change the field.

If you have clinical pharmacology data from human studies, Clinical Pharmacology & Therapeutics is the clear first choice.

If your paper is basic pharmacology with rigorous experimental design, British Journal of Pharmacology rewards methodological quality.

If you're writing a thorough review, Pharmacological Reviews is the gold standard, and Trends in Pharmacological Sciences works for shorter, more conceptual pieces.

If your work focuses on drug resistance, Drug Resistance Updates is hard to beat.

If you need accessible, fast publication with OA, Frontiers in Pharmacology or Pharmacology Research & Perspectives offer practical options.

If you're doing classical receptor or enzyme pharmacology, JPET or Molecular Pharmacology have the right readership.

Pharmacology manuscripts need clean data presentation, proper statistical reporting, and clear mechanistic arguments. Run your manuscript through Manusights' free AI review before submitting. The tool catches common issues with figure quality, statistical reporting, and argument structure that pharmacology reviewers are trained to spot. A polished first submission saves weeks or months of revision.